US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

1  2    4    6  7  8  9  10  
Brain Edema - Pipeline Review, H1 2016
5/31/2016 | published by: Global Markets Direct
... therapeutics under development for Brain Edema, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Migrane Drugs market - Market size, segmentation, market share and competitive landscape (2016-2021)
6/1/2016 | published by: Mordor Intelligence LLP
... XX million by the end of 2021. The CAGR during this period of forecast is XX%. The increasing migraine prevalence rate and continuous collaboration from pharma players are some of the primary factors propelling the ...  |  read more...
USD 500
Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2016
5/31/2016 | published by: Global Markets Direct
... information on the therapeutics under development for Amyotrophic Lateral Sclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the ...  |  read more...
USD 2,000
Schizophrenia - Pipeline Review, H1 2016
5/31/2016 | published by: Global Markets Direct
... for Schizophrenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Brain Hemorrhage - Pipeline Review, H1 2016
5/31/2016 | published by: Global Markets Direct
... therapeutics under development for Brain Hemorrhage, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2016
5/31/2016 | published by: GlobalData
... report provides top line data relating to the clinical trials on Glioblastoma Multiforme (GBM). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ...  |  read more...
USD 2,500
Essential Tremor - Pipeline Review, H1 2016
5/31/2016 | published by: Global Markets Direct
... therapeutics under development for Essential Tremor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Global Migraine Market Report: 2016 Edition
5/1/2016 | published by: Koncept Analytics
... lights and sounds. Migraines are thought to result from the activation and sensitization of sensory neurons that have nerve endings in meningeal blood vessels. Migraines can be episodic or chronic. Chronic Migraine (CM) and Episodic ...  |  read more...
USD 800
Mental Illness Drugs Markets in China
5/1/2016 | published by: Asia Market Information & Development Company
... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ...  |  read more...
USD 4,000
Central Nervous System Disorder Drugs Markets in China
5/1/2016 | published by: Asia Market Information & Development Company
... will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. ...  |  read more...
USD 4,000
Central Nervous System Disorder Drugs Industry Forecasts - China Focus
5/1/2016 | published by: Asia Market Information & Development Company
... fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far ...  |  read more...
USD 1,000
Mental Illness Drugs Companies in China
5/1/2016 | published by: Asia Market Information & Development Company
... dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies ...  |  read more...
USD 1,800
Global Migraine Drugs Market 2016-2020
5/2/2016 | published by: TechNavio - Infiniti Research Ltd.
... the fluctuating levels of hormones in their bodies. Therapeutic agents such as anti-inflammatory painkillers, antimigraine drugs, antisickness medicines, and triptans are used for the treatment of the disease. Technavio’s analysts forecast the global migraine drugs ...  |  read more...
USD 2,500
Germany Bipolar Disorder Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Bipolar Disorder epidemiology, Bipolar Disorder market valuations and forecast, Bipolar Disorder products sales and competitive landscape in Germany. classified into nine sections – Bipolar Disorder overview including etiology, pathophysiology, and diagnosis, Bipolar Disorder treatment options, ...  |  read more...
USD 990
Global Glioma Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... market valuations and forecast, Glioma products and competitive landscape. The research focuses on key countries such as the US, Germany, France, Italy, Spain, UK, and Japan. This report is classified into eleven sections – Glioma ...  |  read more...
USD 3,970
Japan Bipolar Disorder Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Bipolar Disorder epidemiology, Bipolar Disorder market valuations and forecast, Bipolar Disorder products sales and competitive landscape in Japan. classified into nine sections – Bipolar Disorder overview including etiology, pathophysiology, and diagnosis, Bipolar Disorder treatment options, ...  |  read more...
USD 990
Global Bipolar Disorder Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Bipolar Disorder epidemiology, Bipolar Disorder market valuations and forecast, Bipolar Disorder products and competitive landscape. The research focuses on key countries such as the US, Germany, France, Italy, Spain, UK, and Japan. This report is ...  |  read more...
USD 3,970
Italy Schizophrenia Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... market valuations and forecast, Schizophrenia products sales and competitive landscape in Italy. classified into nine sections – Schizophrenia overview including etiology, pathophysiology, and diagnosis, Schizophrenia treatment options, Schizophrenia pipeline products, Schizophrenia market analysis comprising of ...  |  read more...
USD 990
US Fibromyalgia Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... market valuations and forecast, Fibromyalgia products sales and competitive landscape in the US. classified into nine sections – Fibromyalgia overview including etiology, pathophysiology, and diagnosis, Fibromyalgia treatment options, Fibromyalgia pipeline products, Fibromyalgia market analysis comprising ...  |  read more...
USD 990
US Glioma Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... market valuations and forecast, Glioma products sales and competitive landscape in the US. classified into nine sections – Glioma overview including etiology, pathophysiology, and diagnosis, Glioma treatment options, Glioma pipeline products, Glioma market analysis comprising ...  |  read more...
USD 990
Japan Fibromyalgia Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... market valuations and forecast, Fibromyalgia products sales and competitive landscape in Japan. classified into nine sections – Fibromyalgia overview including etiology, pathophysiology, and diagnosis, Fibromyalgia treatment options, Fibromyalgia pipeline products, Fibromyalgia market analysis comprising of ...  |  read more...
USD 990
Japan Glioblastoma Multiforme Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Glioblastoma Multiforme epidemiology, Glioblastoma Multiforme market valuations and forecast, Glioblastoma Multiforme products sales and competitive landscape in Japan. classified into nine sections – Glioblastoma Multiforme overview including etiology, pathophysiology, and diagnosis, Glioblastoma Multiforme treatment options, ...  |  read more...
USD 990
Europe Opioid Addiction Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Opioid Addiction epidemiology, Opioid Addiction market valuations and forecast, Opioid Addiction products sales and competitive landscape. The research focuses on key countries such as Germany, France, Italy, Spain, and UK. This report is classified into ...  |  read more...
USD 2,920
Germany Schizophrenia Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... market valuations and forecast, Schizophrenia products sales and competitive landscape in Germany. classified into nine sections – Schizophrenia overview including etiology, pathophysiology, and diagnosis, Schizophrenia treatment options, Schizophrenia pipeline products, Schizophrenia market analysis comprising of ...  |  read more...
USD 990
Spain Schizophrenia Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... market valuations and forecast, Schizophrenia products sales and competitive landscape in Spain. classified into nine sections – Schizophrenia overview including etiology, pathophysiology, and diagnosis, Schizophrenia treatment options, Schizophrenia pipeline products, Schizophrenia market analysis comprising of ...  |  read more...
USD 990
1  2    4    6  7  8  9  10